Return to study ST001288 main page

Download data matrix(Subcellular organelle lipidomics in TLR-4-activated macrophages Reversed phase and normal phase LC)

AnalysisSamplesFactorsUnits
Reversed phase and normal phase LCS31Fraction:Cytosol | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS32Fraction:Cytosol | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS33Fraction:Cytosol | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS34Fraction:Cytosol | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS35Fraction:Cytosol | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS36Fraction:Cytosol | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS25Fraction:Dense microsomes | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS26Fraction:Dense microsomes | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS27Fraction:Dense microsomes | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS28Fraction:Dense microsomes | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS29Fraction:Dense microsomes | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS30Fraction:Dense microsomes | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS13Fraction:ER | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS14Fraction:ER | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS15Fraction:ER | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS16Fraction:ER | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS17Fraction:ER | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS18Fraction:ER | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS7Fraction:Mitochondria | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS8Fraction:Mitochondria | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS9Fraction:Mitochondria | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS10Fraction:Mitochondria | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS11Fraction:Mitochondria | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS12Fraction:Mitochondria | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS1Fraction:Nucleus | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS2Fraction:Nucleus | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS3Fraction:Nucleus | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS4Fraction:Nucleus | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS5Fraction:Nucleus | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS6Fraction:Nucleus | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS19Fraction:Plasma membrane | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS20Fraction:Plasma membrane | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS21Fraction:Plasma membrane | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS22Fraction:Plasma membrane | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS23Fraction:Plasma membrane | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS24Fraction:Plasma membrane | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS37Fraction:Whole cells | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS38Fraction:Whole cells | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS39Fraction:Whole cells | Treatment:Controlpmol/mg protein
Reversed phase and normal phase LCS40Fraction:Whole cells | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS41Fraction:Whole cells | Treatment:KLApmol/mg protein
Reversed phase and normal phase LCS42Fraction:Whole cells | Treatment:KLApmol/mg protein
  logo